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RESUMO
Introdução: O tratamento endovascular dos aneurismas da aorta reduziu as taxas de transfusão. Não existem recomendações relati-
vamente às unidades de glóbulos vermelhos a serem tipadas por crossmatch pré-operatoriamente. O nosso objetivo é contribuir para 
a análise das unidades de glóbulos vermelhos necessárias no tratamento endovascular dos aneurismas da aorta e na cirurgia híbrida 
de aneurismas da aorta e definir um protocolo do Maximum Surgical Blood Orders Schedule.
Material e Métodos: Analisámos retrospetivamente a base de dados prospectiva dos doentes tratados eletivamente por tratamento 
endovascular dos aneurismas da aorta, entre 2001 e 2012. Analisamos idade, género, classe ASA, Maximum Surgical Blood Orders 
Schedule, unidades de glóbulos vermelhos transfundidas e tempos, endoprótese, relação unidades de glóbulos vermelhos consumi-
das/endoprótese, relação unidades crossmatched/transfundidas, conversão para cirurgia convencional, hemoglobina pré-operatória 
e na alta.
Resultados: Selecionamos para análise 187 doentes, 90% homens, idade média 73,1, classe ASA III mais frequente. Usamos pró-
teses aorto-bi-iliaca em 71%, aorto-uni-iliaca 23% e torácica 6%. Não necessitaram transfusão 72,6%. Transfundimos 171 unidades 
de glóbulos vermelhos. A relação unidades crossmatched/transfundidas foi 10,1 até 2010 e 7,3 após. A relação unidades de glóbulos 
vermelhos consumidas/endoprótese nas primeiras 24 horas foi 0,21 unidades de glóbulos vermelhos/aorto-bi-iliaca, 0,46 unidades de 
glóbulos vermelhos/aorto-uni-iliaca, 0,8 unidades de glóbulos vermelhos/torácica, 1,3 unidades de glóbulos vermelhos/híbrida-torácica 
e duas unidades de glóbulos vermelhos/híbrida-aorto-bi-iliaca. Obtivemos relação estatisticamente significativa entre unidades de 
glóbulos vermelhos transfundidas/endoprótese (p < 0,001) e entre classificação ASA e unidades de glóbulos vermelhos transfundidas 
após 24 h (p < 0,01).
Discussão: As recomendações da British Society of Haematology baseiam-se numa relação unidades crossmatched/transfundidas de 
2:1. Na nossa instituição, a relação unidades crossmatched/transfundidas foi de 10,1 até 2010 e 7,3 de 2011 a 2012.
Conclusões: Os resultados mudaram o nosso Maximum Surgical Blood Orders Schedule para o tratamento endovascular dos 
aneurismas da aorta. Atualmente procedemos ao teste “type and screen” para próteses aorto-bi-iliaca e aorto-uni-iliaca e a testes de 
crossmatch de duas unidades de glóbulos vermelhos para torácica, três para híbrida-torácica e quatro para híbrida-abdominal. Isto 
pode levar a menos gastos, aumento de eficácia e reduzir a sobrecarga no departamento de hematologia.
Palavras-chave: Aneurismas da Aorta/cirugia; Procedimentos Endovasculares; Protocolos Clínicos; Transfusão de Sangue.
ABSTRACT
Introduction: Comparatively to open repair, endovascular aneurysm repair has reduced transfusion rates but there’s no recommendation 
about number of red blood cells units to be crossmatched preoperatively. Our aim is contribute to the analysis of red blood cells units 
needs in endovascular and hybrid aortic aneurysm repair and developing a protocol for maximum surgical blood orders schedule.
Material and Methods: We retrospectively analyzed our prospective database of elective endovascular aneurysm repair from 2001 to 
2012. We analyzed patients’ age, gender, ASA classification, maximum surgical blood orders schedule, red blood cells units transfused 
and timings, types of endoprosthesis, red blood cells units consumption/endoprosthesis’ type ratio, crossmatch to transfusion ratio, 
conversion to open repair, hemoglobin concentrations before surgery and discharge.
Results: We selected 187 patients, 90% men, mean age 73.1, ASA mode III. The endoprosthesis were aorto-bi-iliac in 71%, aorto-uni-
iliac in 23% and thoracic in 6%. Of these, 72.6% of the patients did not require blood transfusion. We transfused 171 red blood cells 
units. Crossmatch to transfusion ratio was 10.1 until 2010 and 7.3 after. The ratio of red blood cells units consumption/endoprosthesis in 
the first 24 hours was 0.21 red blood cells units/aorto-bi-iliac, 0.46 red blood cells units/aorto-uni-iliac, 0.8 red blood cells units/thoracic, 
1.3 red blood cells units/hybrid-thoracic and 2 red blood cells units/hybrid-aorto-bi-iliac. A statistical correlation was observed between 
red blood cells units transfused postoperatively and type of endoprosthesis (p < 0.001) and between ASA classification and red blood 
cells units transfused after 24 hours (p < 0.01).
Discussion: Guidelines from the British Society of Haematology are based on a crossmatch to transfusion ratio of 2:1. Our crossmatch 
to transfusion ratio was 10.1 until 2010 and 7.3 from 2011 to 2012.
Conclusion: These results changed our policy of maximum surgical blood orders schedule for endovascular aneurysm repair. We now 
type and screen aorto-bi-iliac and aorto-uni-iliac. We crossmatch two red blood cells units for thoracic, three red blood cells units for 
hybrid thoracic and four red blood cells units for hybrid abdominal procedures. This may lead to financial savings, improved efficiency 
and reduce workload in hematology department.
Keywords: Aortic Aneurysm/surgery; Blood Transfusion; Clinical Protocols; Endovascular Procedures.
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INTRODUCTION
 Endovascular aneurysm repair (EVAR) was originally 
developed for patients considered ineligible for open 
surgical repair.1 Since then, this minimally invasive method 
of treatment has become the first choice for anatomical 
suitable aortic aneurisms.
 EVAR is associated with a lower morbidity, mortality, 
hospital stay and blood loss.2-4 Blood loss in EVAR is due 
to sheaths, catheters and delivery system exchanges5 or 
surgical complications (access related problems, aneurysm 
or iliac artery rupture or inaccurate device deployment). 
In 2013 Montán et al, concluded that open femoral artery 
access, branched and uniiliac endografts, introducer size 
and aneurysm diameter were all associated with more 
perioperative bleeding.6 Also, up to 10% of elective EVAR 
from his series had a perioperative blood loss exceeding 
1 liter and 2% over 2 liters, which was independently 
associated with higher morbidity and mortality. Despite 
these sources of blood loss, there is clear documented 
evidence that elective EVAR has reduced blood loss and 
consequently transfusion rates. Studies suggest that EVAR 
is associated with a perioperative bleeding between 200 – 
400 mL, lower than 1000-1500 mL observed for open repair
 Acute surgical conversion is a rare complication 
affecting 1.1% and blood transfusion is required in 69.4% 
of these patients.7 As it is a rare event it is difficult to study 
and there is not an at-risk population identifiable. In addition 
to prolonged operative times and higher transfusion rates, 
these patients have higher morbidity and mortality rates.
 Preoperative request of red blood cells units (RBCU) 
often overestimates blood loss8 and little of requested 
RBCU is ultimately used which may cause exhaustion of 
supplies and resources.9 Preoperative over-ordering has 
been documented for nearly 40 years.
 Two basic tests could be performed to type blood: the 
group and screen test that identifies ABO group system 
and the crossmatch tests that full type the sample of blood. 
Crossmatched blood is ready to use but is removed from 
the common pool. Concerning elective procedures it has 
been reported that only 30% of crossmatched blood is used 
which implies a waste of blood and resources.
 There are a lot of indices available to evaluate the 
adequacy of blood ordering and its utilization. In 1975 Boral 
Henry suggested the use of crossmatch to transfusion 
ratio (CTR). The transfusion index (TI) is referent to the 
number of RBCU used per patient crossmatch indicating 
appropriateness of number of RBCU crossmatched. 
The maximal surgical blood order schedule (MSBOS) 
is calculated from the transfusion index and estimates 
RBCU that will be needed for the procedure and can be 
implemented based on audits and in agreement between 
medical teams. By evaluating blood ordering and 
transfusion rates it was possible to develop MSBOS which 
serves as a guide to anticipated blood requirements in a 
surgical procedure and many studies have shown that the 
institutional implementation of MSBOS have led to a safe 
and effective reduction in blood ordering.
 Mann et al, refers that the majority of vascular units 
in the United Kingdom crossmatch four to six RBCU for 
open abdominal aortic aneurysm repair, but there is no 
recommendation for EVAR.10
 We analyzed the RBCU needs in our endovascular 
and hybrid aortic aneurysm repair series and developed a 
protocol of maximum blood orders fitted to each procedure.
MATERIAL AND METHODS
 A retrospective analysis of our prospective database 
of elective endovascular aneurysm repair from 2001 to 
2012 was performed. We analyzed patients’ age, gender, 
American Society Anesthesiologists physical status (ASA) 
classification, maximum surgical blood orders schedule, 
RBCU transfused and timings (first 24 hours postoperative, 
24 hours to 48 hours and after 48 hours), crossmatch 
to transfusion ratio, types of endoprosthesis, RBCU 
consumption/type of endoprosthesis ratio, conversion to 
open repair, hemoglobin concentrations before surgery and 
discharge.
 All EVAR were performed in the operative theatre, using 
C-arm imaging and radiolucent table. A single surgical 
femoral cut-down was done in the thoracic patients and 
bilateral in the abdominals.
 The database is maintained using Microsoft Excel 
(Microsoft Corporation, Santa Rosa, Calif) and analyses 
were performed with SPSS 15.0 software (SPSS Inc, 
Chicago, Ill). Mean, median, mode, minimum, maximum and 
standard deviation values were calculated for the different 
variables. Correlation between values and statistical 
significance for each variable studied was obtained using 
Pearson correlation coefficient. We used the standardized 
p value < 0.05 to consider statistically significance.
RESULTS
 Our results tend to follow a normal distribution.
 For analysis we selected 187 patients with aortic 
aneurismal disease treated between 2001 and 2012. Fifteen 
patients had missing data that led to exclusion of the study.
 There was an increase in the numbers of patients 
treated by year. Since 2009 we treat 30 patients/year. 
 Of the all, 90% of the patients were male.  The mean 
age was 73.1 (between 35 to 92 years) (Fig. 1).
 The ASA classification varied between II and V (Fig. 2).
 The endoprosthesis used were aorto-bi-iliac (ABI) in 121 
patients (71%), aorto-uni-iliac (AUI) in 40 patients (23%) 
and thoracic (THO) in 11 patients (6%). Hybrid surgery 
represented 55% (6 patients) of the thoracic surgeries and 
1.7% (3 patients) of the abdominal surgeries. We observed 
a statistical significant relationship between type of surgery 
and the RBCU transfused (p < 0.001) in every time intervals, 
with a Pearson correlation coefficient, r, of 0.52.
 A total of 171 RBCU were transfused, with an average of 
0.9/patient. Of these, 36% of the RBCU were administrated 
in the first 24 hours after surgery, 34% between 24 to 48 
hours and 30% after 48 hours. 72.6% of patients weren’t 
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transfused (90% of those submitted to ABI, 74% of the AUI, 
60% of the THO), 8.1% of the patients needed 1 RBCU, 
7.6% needed 2 RBCU and 11.7% needed 3 or more RBCU, 
with a maximum of 14 RBCU.
 When we analyzed the relation between ASA 
classification and RBCU transfused we observed a statistical 
significant relationship (p < 0.01) only for transfusions after 
the first 24 hours.
 Until 2010 we routinely crossmatch 4 RBCU for elective 
EVAR and our CTR was 10.1. In 2010 we alter our policy 
and we started to crossmatch 2 RBCU with a CTR of 7.3 
from 2011 to 2012.
 The average hemoglobin concentration loss was 2.5 g/
dL. The average number RBCU spent in the first 24 hours 
of surgery has diminished over the years.
 The ratios of RBCU administrated in the first 24 hours per 
type of procedure/endoprosthesis were 0.21 for ABI, 0.46 
for AUI, 0.8 for THO, 1.3 for hybrid thoracic surgery and 2 
for hybrid abdominal procedures. The blood consumptions 
for each procedure and time interval is shown in Table 1.
 We had no conversion to open repair. 
DISCUSSION
 Overall transfusion rates in EVAR are reported to be 
between 4.2 to 25% and peroperative transfusion rates 
between 13 to 18%. No official MSBOS exists for EVAR. 
Without a MSBOS, preoperative ordering of blood is 
usually based on subjective anticipation of blood loss 
which generally assumes the worst case assumptions and 
overestimates RBCU needed. MSBOS refers to a list of 
surgical procedures and its respective number of RBCU 
to be crossmatched before surgery and its implementation 
allowed improving blood stock management and reducing 
wastage of blood and resources. So each institution should 
create an MSBOS based on their experience and on the 
published literature.
 
Figure 1 - Sex and age distribution of patients with endovascular repair of the aorta at our center from 2001 to 2012
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Figure 2 - ASA grading of the patients
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 Despite major complications rates such as iatrogenic 
rupture are very low during endovascular repair, it can 
lead to life-threatening bleeding and so it requires massive 
transfusion. All institutions must have an emergency 
protocol. In this situation specific blood has no additional 
safety benefit in comparison to O negative.
 In our institution, our global policy is to transfuse when 
hemoglobin is below 8 g/dL, except for special conditions 
like ischemic cardiac disease. Our protocol for emergent 
transfusion is 4 RBCU O negative immediately available. 
Full crossmatched blood is available in 30 min. We 
crossmatch 4 RBCU for open abdominal aortic aneurysm 
repair, similar to the literature. In the beginning of our EVAR 
program we crossmatched 4 RBCU for patient. Due to an 
empirical analysis in 2010 that changed to 2 RBCU. 
 In 2012 there was a significant drop in blood donation in 
Portugal, leading to analysis of the policy for transfusion in 
our surgical department.
 The ideal CTR would be 1 but it means that all 
crossmatched blood were transfused which would be 
unsafe. The British Committee for Standard in Haematology 
Blood Transfusion Task Force recommended that a CTR 
of 2 - 3 is acceptable which would result in 30-50% of 
crossmatched blood being transfused.11 Guidelines from 
the British Society of Haematology (BSH) are based on a 
CTR of 2:1 reinforcing that blood should not be available 
for surgery if the usage is below 50% of requested. These 
guidelines serve only to provide an aid but an individual 
decision must be performed some patients could require 
crossmatch blood ordering independently of the protocol 
such as those with antibodies found in group and save 
screen or those with clot disorders.
 Our CTR was 10.1 until 2010 and 7.3 from 2011 to 2012, 
well above the recommended. The blood consumption 
during endovascular aortic procedures at our center was 
low. In fact no blood was transfused in 156 surgeries. 
The crossmatch of 4 RBCU implies a cost of 32€ and the 
crossmacth of 2 RBCU has a cost of 21€. In the other 
hand, the cost of type and screen is 10€. Until 2010, in 
104 surgeries no RBCU was used and the crossmatch of 
4 RBCU represented a cost of 3 328€. During this period, 
if type and screen had been performed the cost associated 
would have been 1 040€, considerably lower. Between 2011 
and 2012, in 52 surgeries no RBCU was used. During this 
period we crossmatced 2 RBCU which had an associated 
cost of 1 092€, considerable higher than 520€ of type and 
screen strategy.
 In the pursue for our new protocol, we assumed that a 
procedure with less than 0.5 RBCU/surgery/first 24 hours 
in the last years doesn’t need any crossmatched blood, 
so a type and screen strategy was to be put in place. If a 
procedure has a RBCU/surgery/first 24 hours ratio over 0.5 
we crossmatch blood adapted to the type of surgery.
 The ABI grafting had a 0.21 RBCU/surgery/first 24 hours 
ratio, well under 0.5. The AUI grafting associated with femoral 
crossover bypass presented a 0.46 blood units transfused/
surgery ratio. Since March 2013, we only type and screen 
patients that will be submitted to these endovascular aortic 
repairs (representing over 90% of endovascular surgeries).
 TEVAR had a RBCU/surgery/first 24 hours ratio of 0.8. In 
relation with the patient’s security, we defined that 2 RBCU 
should be crossmatched. When the TEVAR is associated 
with aortic arch debranching, our ratio was 1.3, leading 
us to crossmatch 3 RBCU before this kind of procedures. 
The abdominal hybrid surgery had a RBCU/surgery/first 24 
hours ratio of 2. When a patient is to undergo this surgery 4 
RBCU are crossmatched.
 The previous protocol is followed unless the patient has 
some known blood disorder or previous exposure to blood 
transfusions.
 The relation between ASA classification, used to 
define perioperative risk, and blood transfusion was 
already mentioned in literature.12,13 In our experience ASA 
classification is related to postoperative blood transfusion 
after the first 24 hours, so it doesn’t interfere with the 
surgical blood orders schedule. Instead it requires a close 
post operative control of hemoglobin levels in ASA III, IV 
and V patients.
 Our recommendations are the same as Mann et al in 
relation to EVAR, although this previous study did not 
Table 1 – Prevalence of blood transfusions for each procedure during the first 24 hours
Blood used in the first 24 hours
RBCU ABI AUI TEVAR Hybrid TEVAR Hybrid EVAR
0 90.0 74.0 60.0 66.6 33.3
1 5.0 13.0 - - -
2 2.5 8.0 40.0 16.7 33.3
3 0.8 2.5 - - -
4 0.8 2.5 - 16.7 33.3
5 - - - - -
6 0.8 - - - -
7 - - - - -
ABI: aorto-bi-iliac; AUI: aorto-uni-iliac + crossover bypass; TEVAR: endovascular repair of thoracic aneurism; EVAR: endovascular repair of abdominal aortic aneurysm
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differentiate between ABI, AUI, THO and hybrid surgery.
CONCLUSION
 The blood transfusion in endovascular aneurysm repair 
is very low in the ABI and AUI endovascular surgeries. 
Because of the high CTR a type and screen politic can be 
put in place for patients that undergo these procedures. 
This may lead to financial savings, improved efficiency and 
reduce the workload in the hematology department.
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